This hypothesis is supported by clinical studies showing that ALL with a good prognosis, such as TEL/AML1+ ALL, develops in steroid receptor lymphoid progenitors that are prone to undergo apoptosis10. Here, RUNX1 is linked to acute lymphoblastic leukemia.